Topic Hub
15 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 15 of 15 clinical reviews.
Clinically specific dietary, hydration, meal-timing, and lifestyle strategies to reduce mood changes caused by oral micronized progesterone, with evidence-based supplement guidance for patients managing this side effect in real time.
Read clinical reviewEvidence-based dietary strategies to reduce mood side effects from oral micronized progesterone (Prometrium), including specific nutrients, meal timing, and foods that modulate allopregnanolone activity.
Read clinical reviewA clinically actionable, step-by-step protocol for assessing and managing mood changes caused by oral micronized progesterone, including allopregnanolone mechanisms, dose adjustments, timing strategies, and escalation criteria.
Read clinical reviewA clinician-level breakdown of OTC and prescription options for mood changes caused by oral micronized progesterone, including first-line agents, dose ranges, drug interactions to avoid, and when to escalate.
Read clinical reviewA clinically detailed overview of mood side effects from oral micronized progesterone (Prometrium): trial-based incidence rates, who is most at risk, severity patterns, and what to do if symptoms occur.
Read clinical reviewA clinical week-by-week breakdown of mood changes caused by oral micronized progesterone, including onset, peak, resolution, and the trial data behind each phase. Written for patients and prescribers managing this side effect in real time.
Read clinical reviewA clinical severity grading rubric for mood changes caused by oral micronized progesterone (Prometrium), including mechanism, management strategies, and when to contact your prescriber.
Read clinical reviewWhy oral micronized progesterone causes mood changes, how long they last, management strategies, and alternative progestogens that may spare mood. Evidence-based guide with clinical trials and guidelines.
Read clinical reviewA clinician-reviewed deep dive into why oral micronized progesterone changes mood, covering allopregnanolone's GABA-A effects, dose timing, and evidence-based management strategies.
Read clinical reviewLearn when mood changes from oral micronized progesterone require medical attention, how to manage them, and why this hormone affects your brain chemistry.
Read clinical reviewWhen mood changes from oral micronized progesterone persist beyond the expected adjustment period, here is what to evaluate, when to switch formulations, and how to work with your prescriber.
Read clinical reviewEvidence-based supplements to manage mood changes caused by oral micronized progesterone, including magnesium, vitamin B6, omega-3s, and adaptogens with clinical trial data.
Read clinical reviewA clinical deep-dive into how slowing titration, pausing, stepping down, and microdosing oral micronized progesterone can resolve mood-related side effects, with real protocols and decision points for patients and prescribers.
Read clinical reviewA clinician-grade threshold guide for patients and prescribers deciding whether mood changes on oral micronized progesterone warrant dose adjustment, formulation switch, or full discontinuation. Covers severity criteria, timeline, QoL metrics, and alternatives.
Read clinical reviewA clinical-grade explanation of how oral micronized progesterone and its neuroactive metabolite allopregnanolone act on GABA-A receptors to produce mood changes, with actionable management steps for patients and prescribers.
Read clinical review